Evidence map›Paper›PMID 24591373›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2014

NOD2 regulates CXCR3-dependent CD8+ T cell accumulation in intestinal tissues with acute injury.

Xingxin Wu, Amit Lahiri, G Kenneth Haines, Richard A Flavell, Clara Abraham

Registry-linked trialOpen access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02721719 (The Role of CD4+ T Cell Subsets in the Mechanism of Action of Vedolizumab in Ulcerative Colitis), which is not on this map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02721719 unknown statusnot on this mapstarted 2016, after this paper: background citation

The Role of CD4+ T Cell Subsets in the Mechanism of Action of Vedolizumab in Ulcerative Colitis

TypeobservationalSponsorUniversity of British ColumbiaRan2016 to 2024Enrolled50ConditionsUlcerative Colitis
3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 32 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Adipose-derived stem cells integrate into trabecular meshwork with glaucoma treatment potential.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2020
    Article
  11. Article
  12. Article
  13. Nod2 Deficiency Augments Th17 Responses and Exacerbates Autoimmune Arthritis.Journal of immunology (Baltimore, Md. : 1950) · 2018
    Article
  14. Trigger-happy resident memory CD4Mucosal immunology · 2018
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Xingxin WuDepartment of Medicine, Yale University School of Medicine, New Haven, CT 06520;
Amit Lahiri
G Kenneth Haines
Richard A Flavell
Clara Abraham
Yale University · US

Funding

Yale Liver CenterP30DK034989 · NIDDK · YALE UNIVERSITY · PI YASUKO IWAKIRI · 1986 to 2026
$31.1M
Yale University Inflammatory Bowel Disease Genetics Research CenterU01DK062422 · NIDDK · YALE UNIVERSITY · PI Ling-shiang Chuang · 2002 to 2026
$10.8M
Functional outcomes of inflammatory bowel disease associated variantsR01DK099097 · NIDDK · YALE UNIVERSITY · PI CLARA ABRAHAM · 2013 to 2026
$7.0M
Yale Autoimmunity Center of ExcellenceU19AI082713 · NIAID · YALE UNIVERSITY · PI CHO, JUDY H. · 2009 to 2013
$3.6M
Mechanisms of Chronic Nod2-mediated Effects in Human MacrophagesR01DK077905 · NIDDK · YALE UNIVERSITY · PI ABRAHAM, CLARA · 2008 to 2012
$1.7M
IL-23/Th17 pathways and Inflammatory Bowel DiseaseR56AI089789 · NIAID · YALE UNIVERSITY · PI ABRAHAM, CLARA · 2012 to 2012
$415k
NIAID NIH HHS R56 AI089789NIAID NIH HHS R56AI089789NIAID NIH HHS U19 AI082713NIAID NIH HHS U19-AI082713NIDDK NIH HHS DK062422NIDDK NIH HHS DK-P30-34989NIDDK NIH HHS P30 DK034989NIDDK NIH HHS R01 DK077905NIDDK NIH HHS R01DK077905NIDDK NIH HHS R01 DK099097NIDDK NIH HHS R01DK099097NIDDK NIH HHS U01 DK062422
6 · The paper itself

Abstract

Polymorphisms in NOD2 confer risk for Crohn's disease, characterized by intestinal inflammation. How NOD2 regulates both inflammatory and regulatory intestinal T cells, which are critical to intestinal immune homeostasis, is not well understood. Anti-CD3 mAb administration is used as therapy in human autoimmune diseases, as well as a model of transient intestinal injury. The stages of T cell activation, intestinal injury, and subsequent T tolerance are dependent on migration of T cells into the small intestinal (SI) lamina propria. Upon anti-CD3 mAb treatment of mice, we found that NOD2 was required for optimal small intestinal IL-10 production, in particular from CD8(+) T cells. This requirement was associated with a critical role for NOD2 in SI CD8(+) T cell accumulation and induction of the CXCR3 ligands CXCL9 and CXCL10, which regulate T cell migration. NOD2 was required in both the hematopoietic and nonhematopoietic compartments for optimal expression of CXCR3 ligands in intestinal tissues. NOD2 synergized with IFN-γ to induce CXCL9 and CXCL10 secretion in dendritic cells, macrophages, and intestinal stromal cells in vitro. Consistent with the in vitro studies, during anti-CD3 mAb treatment in vivo, CXCR3 blockade, CD8(+) T cell depletion, or IFN-γ neutralization each inhibited SI CD8(+) T cell recruitment, and reduced chemokine expression and IL-10 expression. Thus, NOD2 synergizes with IFN-γ to promote CXCL9 and CXCL10 expression, thereby amplifying CXCR3-dependent SI CD8(+) T cell migration during T cell activation, which, in turn, contributes to induction of both inflammatory and regulatory T cell outcomes in the intestinal environment.

Indexed as

AnimalsAntibodies, MonoclonalBone Marrow CellsCD3 ComplexCD8-Positive T-LymphocytesCell MovementCells, CulturedChemokine CXCL10Chemokine CXCL9ColitisDendritic CellsFlow CytometryGene ExpressionInterferon-gammaInterleukin-10Intestinal MucosaAntibodies, MonoclonalCD3 ComplexChemokine CXCL10Chemokine CXCL9Cxcr3 protein, mouseInterferon-gammaInterleukin-10Nod2 protein, mouseNod2 Signaling Adaptor ProteinReceptors, CXCR3

Identifiers

PMID24591373
PMCPMC4064676
OpenAlexW2151239430

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.